Thomas Frodl is Professor of Psychiatry and Psychotherapy and Director of the University Hospital of Psychiatry, Psychotherapy and Psychosomatics at the University Hospital RWTH Aachen.
His research experience in systemic neuroscience with the use of imaging and neurophysiological methods as well as their combination with genetic, social environmental factors and immunological markers fits very well into the unique DZP landscape.
Goals are to investigate the regulation and dysregulation of neuronal circuits in association with the signaling pathways of the stress hormone system, the neurotransmitter systems and the immune system and to identify markers helpful for decision support and therapy monitoring. Moreover, his group develops apps for self-management of depression and to support psychotherapeutic processes, such as apps for cognitive bias modification and combined digital remediation programs with local electric current stimulation. Thematic foci here are prevention, (early) diagnosis and therapy of affective disorders, schizophrenias, trauma sequelae and developmental disorders.
In the EU project DeepHealth, the computational group is developing models using Deep Learning to support the diagnosis and therapy of dementia, depression and schizophrenia in the future.